Ocular pain after intravitreal injection.
Maria Rosa Sanabria, Javier A Montero, María Victoria Losada, Marta Fernández-Muñoz, Alicia Galindo, Itziar Fernández, Rosa M Coco, Ana Sampedro
Index: Curr. Eye Res. 38(2) , 278-82, (2013)
Full Text: HTML
Abstract
To evaluate the efficacy of different anesthetics and topical anti-inflammatory treatment in patients undergoing intravitreal injections (IVI).Prospective, randomized, double masked, comparative study. Patients undergoing 0.05 mL IVI were randomized to two different preoperative anesthetic regimes (regime A [0.5% tetracaine + naphazoline] versus regime B [5% lidocaine]) and two different post-injection topical protocols (protocol 1 [tobramycin qid] versus protocol 2 [tobramycin qid + diclofenac qid]). Patients were trained to score pain using a numerical rating pain scale from 0 (no pain) to 10 (excruciating pain) immediately after the injection, 30 min and 24 h later. Patients were instructed to take oral paracetamol (650-1000 mg, adjusted to the patient's weight) every six hours ad lib if necessary.A total of 156 patients were enrolled; 86 patients were randomized to regime A and 70 to regime B; 78 patients were assigned to each of the post-injection topical protocols. The average pain score immediately after the IVI was 2.77 (SD 2.12) for the whole group (2.85, SD 2.23 with tetracaine and 2.67, SD 2.00 with lidocaine; p = 0.73, Mann-Whitney U-test). Twenty-four hours later, the average pain score was 1.84, SD 2.45 (topical diclofenac + tobramycin) versus 1.75, SD 1.83 (topical tobramycin; p = 0.46, Mann-Whitney U-test). Forty-seven patients (30%) required oral paracetamol (average 3.3 and range 1-5 tablets). Conjunctival hemorrhage 30 min after the injection was less frequent and severe in eyes treated with topical naphazoline (p = 0.055, Mann-Whitney U-test).Topical tetracaine and lidocaine provide similar anesthesia before IVI. Topical diclofenac does not seem to reduce pain scores after IVI.
Related Compounds
Related Articles:
2013-05-01
[Pak. J. Pharm. Sci. 26(3) , 641-8, (2013)]
2015-01-01
[J. Pharm. Biomed. Anal. 111 , 333-43, (2015)]
Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK.
2013-07-01
[J. Refract. Surg. 29(7) , 469-75, (2013)]
A presentation of longstanding toxoplasmosis chorioretinitis
2009-01-01
[Optometry 80(1) , 23-8, (2009)]
2011-10-01
[Exp. Cell Res. 317(16) , 2239-51, (2011)]